LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia Ago

The leucine-rich repeat kinase 2 (LRRK2) G2019S mutation is the most common genetic determinant of Parkinson disease (PD) identified to date. It accounts for 1%–7% of PD in patients of European origin and 20%–40% in Ashkenazi Jews and North African Arabs with PD. Previous studies concluded that pati...

詳細記述

保存先:
書誌詳細
主要な著者: Zabetian, Cyrus P., Hutter, Carolyn M., Yearout, Dora, Lopez, Alexis N., Factor, Stewart A., Griffith, Alida, Leis, Berta C., Bird, Thomas D., Nutt, John G., Higgins, Donald S., Roberts, John W., Kay, Denise M., Edwards, Karen L., Samii, Ali, Payami, Haydeh
フォーマット: Artigo
言語:Inglês
出版事項: The American Society of Human Genetics 2006
主題:
Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1592578/
https://ncbi.nlm.nih.gov/pubmed/16960813
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料